Publikationen

Publikationen 2020

  • Frerker B, Hildebrandt G. (2020): Positronenemissionstomographie gestützte Behandlung des Morbus Hodgkin im frühen günstigen Stadium: Endergebnisse der Deutschen Hodgkin Studiengruppe (DHSG). Strahlentherapie und Onkologie. 196(5):488–491. DOI: 10.1007/s00066-020-01600-4. PMID: 32170351.
     
  • Hildebrandt G, Stachs A, Gerber B, Potenberg J, Krug D, Wolter K, Kühn T, Zierhut D, Sedlmayer F, Kaiser J, Reitsamer R, Heil J, Nekljudova V, Bekes I, Loibl S, Reimer T. (2020): Central Review of Radiation Therapy Planning Among Patients with Breast-Conserving Surgery: Results from a Quality Assurance Process Integrated into the INSEMA Trial. Int J Radiat Oncol Biol Phys. 107(4):683–693. DOI:10.1016/j.ijrobp.2020.04.042. PMID: 32437921.
     
  • Lange F, Hartung J, Liebelt C, Boisserée J, Resch T, Porath K, Hörnschemeyer J, Reichart G, Sellmann T, Neubert V, Kriesen S, Hildebrandt G, Schültke E, Köhling R, Kirschstein T. (2020): Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model. Front. Neurosci. 14:1260. DOI: 10.3389/fnins.2020.598266. PMID: 33328869.
     
  • Manda K, Juerß D, Fischer P, Schröder A, Koenen A, Hildebrandt G (2020): Simvastatin treatment varies the radiation response of human breast cells in 2D or 3D culture. Invest New Drugs. DOI: 10.1007/s10637-020-01046-6. PMID: 33313978.
     
  • Manda K, Kriesen S, Hildebrandt G (2020): The solvent and treatment regimen of sodium selenite cause its effects to vary on the radiation response of human bronchial cells from tumour and normal tissues. Med Oncol 37(12):115. PMID: 33205219.
     
  • Manda K, Präkelt T, Schröder T, Kriesen S, Hildebrandt G (2020): Radiosensitizing effects of trabectedin on human A549 lung cancer cells and HT-29 colon cancer cells. Invest New Drugs 38(4): 967–976. DOI: 10.1007/s10637-019-00852-x. PMID: 31482373.
     
  • Martin D, Balermpas P, Gollrad J, Weiß C, Valentini C, Stuschke M, Schäfer H, Henckenberens C, Debus J, Krug D, Kuhnt T, Brunner T, Bostel T, Engenhart-Cabillic R, Nestle U, Combs S, Belka C, Hautmann M, Hildebrandt G, Gani C, Polat B, Rödel C, Fokas E. (2020): RADIANCE - Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial. Clin Transl Radiat Oncol 23: 43–49. DOI: 10.1016/j.ctro.2020.04.010. PMID: 32420463.
     
  • Strüder D, Hellwig S, Rennau H, van Bonn S, Schraven SP, Mlynski R, Hildebrandt G, Schuldt T. (2020): Screening for irradiation vasculopathy by intima-media thickness sonography in head and neck cancer patients. Eur Arch Otorhinolaryngol. DOI: 10.1007/s00405-020-06301-3. PMID: 32870365.
     
  • Wilhelm M-L, Chan MKH, Abel B, Cremers F, Siebert F-A, Wurster S, Krug D, Wolff R, Dunst J, Hildebrandt G, Schweikard A, Rades D, Ernst F, Blanck O. (2020): Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases. Strahlenther Onkol. DOI: 10.1007/s00066-020-01652-6. PMID: 32588102.
     
  • Zschoche M, Zimpfer A, Scheef BO, Jünemann AM, Guthoff RF, Junghanss C, Hildebrandt G, Emmert S, Erbersdobler A, Kundt G, Kakkassery V. (2020): Histopathological features and ann arbor stage in periocular lymphoma. In Vivo 34(4):1965–1974. DOI: 10.21873/invivo.11993. PMID: 32606168.
     
  • Prehn F, Timmermann E, Kettlitz M, Schaufler K, Günther S, Hahn V. (2020): Inactivation of airborne bacteria by plasma treatment and ionic wind for indoor air cleaning. Plasma Process Polym 17(9): 2000027.
     
  • Schültke E, Bayat S, Bartzsch S, Bräuer-Krisch E, Djonov V, Fiedler S, Fernandez-Palomo C, Jaekel F, Pellicioli P, Trappetti V, Hildebrandt G. (2020): A mouse model for microbeam radiotherapy of the lung. Int J Radiat Oncol Biol Phys. DOI: 10.1016/j.ijrobp.2020.12.030. PMID: 33383127.Frerker B, Hildebrandt G. (2020): Distinguishing radiation pneumonitis from local tumour recurrence following SBRT for lung cancer. Reports in Medical Imaging. 2020;13:1-23. doi.org/10.2147/RMI.S176901.
     
  • Käsmann L, Schröder A, Frey B, Fleischmann DF, Gauer T, Ebert N, Hecht M, Krug D, Niyazi M, Mäurer M, Young DEGRO Group (2020): Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group. Strahlenther Onkol (2020). doi.org/10.1007/s00066-020-01729-2. PMID: 33337507.

Publikationen 2019

  • Schröder S, Juerß D, Kriesen S, Manda K, Hildebrandt G. (2019): Immunomodulatory Properties of low-dose ionizing Radiation on Human Endothelial Cells. Int. J Radiat Biol 95(1):23-32. PMID: 29883248.
     
  • Schröder A, Kriesen S, Hildebrandt G, Manda K. (2019): First insights into the effect of low-dose X-ray irradiation in adipose-derived stem cells. Int. J. Mol. Sci. 20, 6075; doi:10.3390/ijms20236075. PMID: 31810198.
     
  • Boda-Heggemann J, Jahnke A, Chan MKH, Ernst F, Ghaderi AL, Attenberger U, Hunold P, Schäfer JP, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O. (2019): In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations. Radiotherapy and oncology: 134:158–165. DOI: 10.1016/j.radonc.2019.01.023. PMID: 31005210.
     
  • Eidemüller M, Simonetto C, Kundrát P, Ulanowski A, Shemiakina E, Güthlin D, Rennau H, Remmele J, Hildebrandt G, Wolf U. (2019): Long-term health risk after breast-cancer radiotherapy: overview of PASSOS methodology and software. Radiation protection dosimetry 183 (1-2):259–263. DOI: 10.1093/rpd/ncy219. PMID: 30520982.
     
  • Schröder S, Juerß D, Kriesen S, Manda K, Hildebrandt G. (2019): Immunomodulatory properties of low-dose ionizing radiation on human endothelial cells. Int J Radiat Biol. 95(1):23-32. doi: 10.1080/09553002.2018.1486515. PMID: 29883248.
     
  • Hörner-Rieber J, Bernhardt D, Blanck O, Duma M, Eich HT, Gerum S, Gkika E, Hass P, Henkenberens C, Herold HU, Hildebrandt G, Imhoff D, Kahl H, Janssen S, Jurianz K, Krempien R, Lautenschläger SF, Lohaus F, Mueller AC, Petersen C, Sackerer I, Scafa D, Schrade E, Uhlmann L, Wittig A, Guckenberger M. (2019): Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT. Clinical lung cancer 20 (6), e667-e677. DOI: 10.1016/j.cllc.2019.06.024. PMID:31327644.
     
  • Kundrát P, Remmele J, Rennau H, Sebb S, Simonetto C, Eidemüller M, Wolf U, Hildebrandt G. (2019): Inter-patient variability in doses to nearby organs in breast-cancer radiotherapy: inference from anatomic features. Radiation protection dosimetry 183 (1-2):255–258. DOI: 10.1093/rpd/ncy226. PMID:30535311.
     
  • Kundrát P, Remmele J, Rennau H, Sebb S, Simonetto C, Eidemüller M, Wolf U, Hildebrandt G. (2019): Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. Radiotherapy and oncology 131:186–191. DOI: 10.1016/j.radonc.2018.08.022. PMID:30241788.
     
  • Kundrát P, Simonetto C, Eidemüller M, Remmele J, Rennau H, Sebb S, Wolf U, Hildebrandt G. (2019): What anatomic features govern personal long-term health risks from breast cancer radiotherapy? Radiat prot dosimetry. 186(2-3):381-385. DOI: 10.1093/rpd/ncz236. PMID:31711194.
     
  • Schröder S, Broese S, Baake J, Juerß D, Kriesen S, Hildebrandt G, Manda K. (2019): Effect of ionizing radiation on human EA.hy926 endothelial cells under inflammatory conditions and their interactions with A549 tumour cells. J immunol res. 2019:9645481. DOI: 10.1155/2019/9645481. PMID: 31565662.
     
  • Stera S, Balermpas P, Blanck O, Wolff R, Wurster S, Baumann R, Szücs M, Loutfi-Krauss B, Wilhelm ML, Seifert V, Rades D, Rödel C, Dunst J, Hildebrandt G, Arnold A, Meissner M, Kähler KC. (2019): Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma. Melanoma res 29 (2):187–195. DOI: 10.1097/CMR.0000000000000542. PMID:30802230.
     
  • Zimpfer A, Schneider B, Blanck O, Riedel K, Zhivov A, Jonigk D, Erbersdobler A, Jünemann A, Andratschke N, Hildebrandt G, Guthoff RF, Kakkassery V. (2019): Pathologic Features of Tumor Activity and Stability in Uveal Melanoma Specimens after Fractionated CyberKnife Radiosurgery. Pathol oncol res. 25(2):731-740. DOI: 10.1007/s12253-018-00565-1. PMID:30617758.
     
  • Coquery N, Adam JF, Nemoz C, Janvier R, Livingstone J, Chauvin A, Kefs S, Guerineau C, De Saint Jean L, Ocadiz A, Bouchet A, Bartzsch S, Schültke E, Siegbahn A, Bräuer-Krisch E, Lemasson B, Barbier EL, Laissue J, Balosso J, Val-Laillet D, Serduc R. (2019): Locomotion and eating behavior changes in Yucatan minipigs after unilateral radio-induced ablation of the caudate nucleus. Scientific reports 9 (1):17082. DOI: 10.1038/s41598-019-53518-2. PMID:31745153.

Publikationen 2018

  • Stera S, Balermpas P, Chan MKH, Huttenlocher S, Wurster S, Keller C, Imhoff D, Rades D, Dunst J, Rödel C, Hildebrandt G, Blanck O. (2018): Breathing-motion-compensated robotic guided stereotactic body radiation therapy: Patterns of failure analysis. Strahlenther. Onkol. 194(2): 143-155. PMID: 28875297.
     
  • Ghadjar P, Hayoz S, Bernhard J, Zwahlen D, Stein J, Hölscher T, Gut P, Bülent P, Hildebrandt G, Müller AC, Putora MP, Papachristofilou A, Schär C, Dal Pra A, Biaggi-Rudolf C, Wust P, Aebersold DM, Thalmann GN. (2018): Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy. Radiother. Oncol. 126(2): 257-262. PMID: 29103826.
     
  • Baaße A, Juerß D, Reape E, Manda K, Hildebrandt G. (2018): Promoting effects of adipose-derived stem cells on breast cancer cells are reversed by radiation therapy. Cytotechnology 70(2): 701-711. PMID: 29188405.
     
  • Schäfer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Kovacz G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Gall C, Polat B. (2018): Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet  Oncol. 19(6): 834-844. PMID: 29695348.
     
  • Boda-Heggemann J, Jahnke A, Chan M, Ghaderi Ardekani LS, Hunold P, Schäfer JP, Huttenlocher S, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O. (2018): Direct dose correlation of MRI- morphologic alterations of healthy liver tissue after robotic liver-SBRT. Strahlenther. Onkol. 194(5): 414-424. PMID: 29404626.
     
  • Klement RJ, Hörner-Rieber J, Adebahr S, Andratschke N, Blanck O, Boda- Heggemann J, Duma M, Eble MJ, Eich HC, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl KH, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A, Guckenberger M. (2018): Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. Radiother. Oncol. 127(2): 246-252. PMID: 29510865.
     
  • Andratschke N, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M, Hildebrandt G, Klement RJ, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Habermehl D (2018): The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): Patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver metastases in 474 patients with 623 metastases. BMC Cancer 18(1): 283. PMID: 29534687.
     
  • Schültke E, Bräuer-Krisch E, Blattmann H, Requardt H, Laissue JA, Hildebrandt G. (2018): Survival of rats bearing advanced intracerebral F 98 tumors after glutathione depletion and microbeam radiation therapy: conclusions from a pilot project. Radiat. Oncol. 13(1): 89. PMID: 29747666.
     
  • Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O. (2018): Clinical Results of Mean GTV Dose Optimized Robotic Guided Stereotactic Body Radiation Therapy for Lung Tumors. Frontiers in oncology 8: 171. PMID: 29868486.
     
  • Schröder S, Kriesen S, Paape D, Hildebrandt G, Manda K. (2018): Modulation of inflammatory reactions by low dose ionizing radiation: cytokine release of murine endothelial cells is dependent on culture conditions. J Immunol Res. 2018:2856518.doi: 10.1155/2018/2856518. PMID: 29967799.
     
  • Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O. (2018): Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge. Strahlenther Onkol 194 (9), 843–854. PMID: 29802435.
     
  • Baaße A, Machoy F, Juerß D, Baake J, Stang F, Reimer T, Krapohl BD, Hildebrandt G. (2018): Radiation sensitivity of adipose-derived stem cells isolated from breast tissue. Int J Mol Sci. 19(7); doi:10.3390/ijms19071988. PMID: 29986519.
     
  • Bock F, Hildebrandt G. (2018): High-risk endometrial cancer: In each case an adjuvant radiochemotherapy? Strahlenther Onkol. 194(10): 960–961. DOI: 10.1007/s00066-018-1351-x. PMID: 30143813.
     
  • Smith R, Wang J, Seymour C, Fernandez-Palomo C, Fazzari J, Schültke E, Bräuer-Krisch E, Laissue J, Schroll C, Mothersill C. (2018): Homogenous and Microbeam X-Ray Radiation Induces Proteomic Changes in the Brains of Irradiated Rats and in the Brains of Nonirradiated Cage Mate Rats. Dose-response: DOI: 10.1177/1559325817750068. PMID: 29383012.
     
  • Tagliaferri L, Budrukkar A, Lenkowicz J, Cambeiro M, Bussu F, Guinot JL, Hildebrandt G, Johansson B, Meyer JE, Niehoff P, Rovirosa A, Takácsi-Nagy Z, Boldrini L, Dinapoli N, Lanzotti V, Damiani A, Gatta R, Fionda B, Lancellotta V, Soror T, Monge RM, Valentini V, Kovács G. (2018): ENT COBRA ONTOLOGY: the covariates classification system proposed by the Head & Neck and Skin GEC-ESTRO Working Group for interdisciplinary standardized data collection in head and neck patient cohorts treated with interventional radiotherapy (brachytherapy). J. Contemp. Brachytherapy.  10(3): 260–266. DOI: 10.5114/jcb.2018.76982. PMID: 30038647.
     
  • Timmermann E, Prehn F, Schmidt M, Höft H, Brandenburg R, Kettlitz M. (2018): Indoor air purification by dielectric barrier discharge combined with ionic wind: physical and microbiological investigations. In: J. Phys. D: Appl. Phys. 51(16):164003. DOI: 10.1088/1361-6463/aab48b.

Publikationen 2017

  • Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO). Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol.; 259-268. (2017). PMID:28094198.
  • Tanadini-Lang S, Rieber J, Filippi AR, Fode MM, Streblow J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A, Høyer M, Ricardi U, Sterzing F, Guckenberger M. Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiother Oncol; pii: S0167-8140(17)30008-7. (2017). PMID:28169042.
  • Chan M, Grehn M, Cremers F, Siebert FA, Wurster S, Huttenlocher S, Dunst J, Hildebrandt G, Schweikard A, Rades D, Ernst F, Blanck O. Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases. Int J Radiat Oncol Biol Phys.; 97(4):839-848. (2017). PMID:28244421.
  • Klement RJ, Guckenberger M, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Habermehl D, Hildebrandt G, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Andratschke N. Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. Radiother Oncol.; pii: S0167-8140(17)30038-5. (2017). PMID:28274491.
  • Reimer T, Stachs A, Nekljudova V, Loibl S, Hartmann S, Wolter K, Hildebrandt G, Gerber B.Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1-2) in the Context of Breast Conserving Therapy: First Results Following Commencement of the Intergroup-Sentinel-Mamma (INSEMA) Trial. Geburtshilfe Frauenheilkd.; 77(2):149-157. (2017). PMID:28331237.

Publikationen 2016

  • Leuchter M, Kalata P, Hildebrandt G, Zettl H, Hakenberg OW. [The parameter "relative survival": Analysis of regional cancer registry data for prostate cancer]. Urologe A.;55(2):156-66. (2016). PMID:26358437.
  • Manapov F, Niyazi M, Gerum S, Roengvoraphoj O, Eze C, Li M, Hildebrandt G, Fietkau R, Klautke G, Belka C. Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy. BMC Cancer.; 16:216. (2016). PMID:26975407.
  • Blanck O, Wang L, Baus W, Grimm J, Lacornerie T, Nilsson J, Luchkovskyi S, Palazon Cano I, Shou Z, Ayadi M, Treuer H, Viard R, Siebert FA, Chan MK, Hildebrandt G, Dunst J, Imhoff D, Wurster S, Wolff R, Romanelli P, Lartigau E, Semrau R, Soltys SG, Schweikard A. Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial. J Appl Clin Med Phys.; 17(3):6151.(2016). PMID:27167291.
  • Andratschke N, Parys A, Stadtfeld S, Wurster S, Huttenlocher S, Imhoff D, Yildirim M, Rades D, Rödel CM, Dunst J, Hildebrandt G, Blanck O. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol.; 11:74. (2016). PMID:27236333.
  • Rieber J, Streblow J, Uhlmann L, Flentje M, Duma M, Ernst I, Blanck O, Wittig A, Boda-Heggemann J, Krempien R, Lohaus F, Klass ND, Eble MJ, Imhoff D, Kahl H, Petersen C, Gerum S, Henkenberens C, Adebahr S, Hass P, Schrade E, Wendt TG, Hildebrandt G, Andratschke N, Sterzing F, Guckenberger M. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Lung Cancer.; 97:51-8. (Epub 2016). PMID:27237028.
  • Mathias D, Mitchel RE, Barclay M, Wyatt H, Bugden M, Priest ND, Whitman SC, Scholz M, Hildebrandt G, Kamprad M, Glasow A. Correction: Low-Dose Irradiation Affects Expression of Inflammatory Markers in the Heart of ApoE -/- Mice. PLoS One. ; 11(6) (2016). PMID:27280530 (Erratum for PMID:25799423).
  • Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Łyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Kortmann RD, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO). GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. Radiother Oncol.; 120(1):119-23.(2016). PMID:27422584.
  • Fernandez-Palomo C, Schültke E, Bräuer-Krisch E, Laissue JA, Blattmann H, Seymour C, Mothersill C. Investigation of Abscopal and Bystander Effects in Immunocompromised Mice After Exposure to Pencilbeam and Microbeam Synchrotron Radiation. Health Phys.; 111(2):149-59. (2016). PMID:27356059.
  • Nitsch S, Hakenberg OW, Heuschkel M, Dräger D, Hildebrandt G, Krause BJ, Schwarzenböck SM.Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging. J Nucl Med.; 57(Suppl 3):38S-42S. (2016) PMID:27694169.
  • Rieber J, Abbassi-Senger N, Adebahr S, Andratschke N, Blanck O, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Lohr F, Petersen C, Schrade E, Streblow J, Uhlmann L, Wittig A, Sterzing F, Guckenberger M. Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease. Int J Radiat Oncol Biol Phys. (2016). PMID:27843031.
  • Roengvoraphoj O, Eze C, Niyazi M, Li M, Hildebrandt G, Fietkau R, Belka C, Manapov F. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy. Strahlenther Onkol.; 193(2):150-155. (Epub 2016). PMID:27853828.
  • Manapov F, Eze C, Niyazi M, Roengvoraphoj O, Li M, Hegemann NS, Hildebrandt G, Fietkau R, Belka C. Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort. J Cancer.; 7(14):2012-2017. (2016). PMID:27877216.
  • Eze C, Roengvoraphoj O, Niyazi M, Hildebrandt G, Fietkau R, Belka C, Manapov F. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging. Clin Lung Cancer; pii: S1525-7304(16)30359-X. (2016). PMID:28065620.
  • Ghadjar P, Hayoz S, Genitsch V, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int. (2016). PMID:27987524.
  • Blanck O, Wang L, Baus W, Grimm J, Lacornerie T, Nilsson J, Luchkovskyi S, Cano IP, Shou Z, Ayadi M, Treuer H, Viard R1 Siebert FA, Chan MK, Hildebrandt G, Dunst J, Imhoff D, Wurster S, Wolff R, Romanelli P, Lartigau E, Semrau R, Soltys SG, Schweikard A. Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial. J Appl Clin Med Phys. May; 17(3):313-330. (2016). PMID:28297348.

Publikationen 2015

  • Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO). 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet (2015) in print. doi: 10.1016/S0140-6736(15)00471-7. PMID:26494415.
  • Andratschke NH, Nieder C, Heppt F, Molls M, Zimmermann F. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival. Radiat Oncol. (2015) in print. doi: 10.1186/s13014-015-0369-9. PMID:25889512.
  • Blanck O, Masi L, Damme MC, Hildebrandt G, Dunst J, Siebert FA, Poppinga D, Poppe B. Film-based delivery quality assurance for robotic radiosurgery: Commissioning and validation.Phys Med. 31(5):476-483 (2015). PMID:26003217.
  • Lewitzki V, Andratschke N, Kuhnt T, Hildebrandt G. Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib. Radiat Oncol. (2015)10(1):29. PMID:25631068.
  • Mathias D, Mitchel RE, Barclay M, Wyatt H, Bugden M, Priest ND, Whitman SC, Scholz M, Hildebrandt G, Kamprad M, Glasow A. Low-dose irradiation affects expression of inflammatory markers in the heart of ApoE-/- mice. PLoS One. (2015) in print; doi: 10.1371/journal.pone.0119661. PMID:25799423.
  • Szücs M, Kuhnt T, Punke C, Witt G, Klautke G, Kramp B, Hildebrandt G. Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypo-pharyngeal cancer.J Radiat Res. 56(1):159-168 (2015). PMID:25348250.
  • Baumgart T, Kriesen S, Neels O, Hildebrandt G, Manda K. Investigation of epothilone B-induced cell death mechanisms in human epithelial cancer cells – in consideration of combined treatment with ionising radiation. Cancer Invest. 33(6):213-224 (2015). PMID:25919223.
  • Lewitzki V, Andratschke N, Kuhnt T, Hildebrandt G. Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib. Radiat Oncol. 10(1):29 (2015). PMID:25631068.
  • Patties I, Haagen J, Dörr W, Hildebrandt G, Glasow A. Late inflammatory and thrombotic changes in irradiated hearts of C57BL/6 wild-type and atherosclerosis-prone ApoE-deficient mice.Strahlenther Onkol. 191(2):172-179 (2015). PMID:25200359.
  • Fernandez-Palomo C, Mothersill C, Bräuer-Krisch E, Laissue J, Seymour C, Schültke E. γ-H2AX as a marker for dose deposition in the brain of wistar rats after synchrotron microbeam radiation. PLoS One. 23; 10(3) (2015). PMID:25799425.
  • Rösche J, Piek J, Hildebrandt G, Grossmann A, Kirschstein T, Benecke R. [Perampanel in the treatment of a patient with glioblastoma multiforme without IDH1 mutation and without MGMT promotor methylation]. Fortschr Neurol Psychiatr. 2015; 83(5):286-9. (2015). PMID:26018396.
  • Fricke S, Ackermann M, Stolzing A, Schimmelpfennig C, Hilger N, Jahns J, Hildebrandt G, Emmrich F, Ruschpler P, Pösel C, Kamprad M, Sack U. Correction: Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment. PLoS One. 14; 10(8)(2015). PMID:26273840 (Erratum for PMID:19582154).
  • Bravin A, Olko P, Schültke E, Wilkens JJ. SYRA3 COST Action--Microbeam radiation therapy: Roots and prospects. Phys Med.; 31(6):561-3.(Epub 2015). PMID:26123367.
  • Fernandez-Palomo C, Bräuer-Krisch E, Laissue J, Vukmirovic D, Blattmann H, Seymour C, Schültke E, Mothersill C. Use of synchrotron medical microbeam irradiation to investigate radiation-induced bystander and abscopal effects in vivo. Phys Med.; 31(6):584-95. (Epub 2015). PMID:25817634.
  • Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. J Clin Oncol. 2015; 33(35):4158-66. (Epub 2015). PMID:26527774.

Publikationen 2014

  • Zimpfer A, Janke S, Hühns M, Schneider B, Kundt G, Zettl H, Kilic E, Maruschke M, Hakenberg OW, Erbersdobler A. C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma. Pathol Res Pract. 210(8):521-525 (2014). PMID:24875296.
  • Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.Biochem Pharmacol. 92(2):312-325 (2014). PMID:25069049.
  • Patties I, Habelt B, Rosin B, Dörr W, Hildebrandt G, Glasow A. Late effects of local irradiation on the expression of inflammatory markers in the arteria saphena of C57/BL6 wildtype and ApoE-knockout mice.Radiat Environ Biophys. 53(1):117-124 (2014). PMID:24071970.
  • Manda K, Kavanagh J, Buttler D, Prise KM, Hildebrandt G. Low dose effects of ionizing radiation on normal tissue stem cells. Mutat Res. 761:6-14 (2014). PMID:24566131.
  • Zimpfer A, Maruschke M, Rehn S, Kundt G, Litzenberger A, Dammert F, Zettl H, Stephan C, Hakenberg OW, Erbersdobler A. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microassays.BJU Int. 114(2):296-302 (2014). PMID:24215118.
  • Nylund R, Lemola E, Hartwig S, Lehr S, Acheva A, Jahns J, Hildebrandt G, Lindholm C. Profiling of low molecular weight proteins in plasma from locally irradiated individuals.J Radiat Res. 55(4):674-682 (2014). PMID:24570173.
  • Oelkrug C, Hilger N, Schönfelder U, Boltze J, Sack U, Fricke C, Hildebrandt G, Keller T, Emmrich F, Fricke S. Modelling hematological parameters after total body irradiation.Int J Radiat Biol. 90(7):538-546 (2014). PMID:24605769.
  • Acheva A, Aerts A, Rombouts C, Baatout S, Salomaa S, Manda K, Hildebrandt G, Kämäräinen M. Human 3-D tissue models in radiation biology: current status and future perspectives.Int J Radiat Res. 12:81-98 (2014). Keine PMID.
  • Semrau S, Zettl H, Hildebrandt G, Klautke G, Fietkau R. Older patients with inoperable non-small-cell lung cancer: Long-term survival after concurrent chemoradiotherapy.Strahlenther Onkol. 190(12):1125-1132 (2014). PMID:25098688.
  • Schültke E, Astolfo A, Pinzer B, Menk RH, Stampanoni M, Arfelli F, Harsan LA, Nikkhah G. Synchrotron X-ray CT imaging with gold nanoparticles in a small animal model: comparison of image modalities.J Synchrotron Radiat. 21(Pt 1):242-50 (2014). PMID:24365943.
  • Lopez WO, Nikkhah G, Schültke E, Furlanetti L, Trippel M. Stereotactic planning software for human neurotransplantation: suitability in 22 surgical cases of Huntington's disease. Restor Neurol Neurosci. 32(2):259-68 (2014). PMID:24164802.
  • Nieder C, Andratschke NH, Grosu AL. Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.Oncol Lett. 8(3):972-976 (2014). PMID:25120644.
  • Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O, Deutschen Gesellschaft für Radioonkologie (DEGRO). Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.Strahlenther Onkol. 190(1):26-33 (2014). PMID:24052011.

Publikationen 2013

  • Manapov F, Klöcking S, Niyazi M, Oskan F, Niemöller O, Belka C, Hildebrandt G, Fietkau R, Klautke G. Timing of failure in limited disease (stage I-III) small-cell lung cancer patients treated with chemoradiotherapy: a retrospective analysis.Tumori. 99(6):656-660 (2013). PMID:24503787.
  • Küchenmeister U, Kuhnt T, Knauerhase H, Hildebrandt G. Indikationen zur Strahlentherapie beim lokal rezidivierten Mammakarzinom.Der Onkologe. 19(6):481-6 (2013).
  • Protzel C, Kakies C, Schwarzenboeck S, Kuhnt T, Erbersdobler A, Krause B, Hakenberg OW. Das Peniskarzinom. Der Onkologe. 19(2):149-52 (2013).
  • Schwarzenböck SM, Kurth J, Gocke C, Kuhnt T, Hildebrandt G, Krause BJ. Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer. Eur J Nucl Med Mol Imaging. 40(1):S28-35 (2013). PMID:23576101.
  • Fietkau R, Lewitzki V, Kuhnt T, Hölscher T, Hess CF, Berger B, Wiegel T, Rödel C, Niewald M, Hermann RM, Lubgan D. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: Results of a randomized, controlled, multicenter trial. Cancer. 119(18):3343-53 (2013). PMID:23765693.
  • Zimpfer A, Rehn S, Litzenberger A, Dammert F, Zettl H, Stephan C, Hakenberg OW, Maruschke M, Erbersdobler A. Expression of EpCAM and KIT in renal tumors: diagnostic and prognostic implication in 948 cases. 97. Jahrestagung der Deutschen Gesellschaft für Pathologie, 23.-26.05.2013 in Heidelberg. Der Pathologe. 34 (Sonderheft 1):18 (2013).
  • Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys. 87(3):534-41 (2013). PMID:23972722.
  • Zhivov A, Winter K, Peschel S, Stachs O, Wree A, Hildebrandt G, Guthoff R. Changes in the micromorphology of the corneal subbasal nerve plexus in patients after plaque brachytherapy.Radiat Oncol. 8(1):136 (2013). PMID:23759072.
  • Keller S, Müller K, Kortmann RD, Wolf U, Hildebrandt G, Liebmann A, Micke O, Flemming G, Baaske D. Efficacy of low-dose radiotherapy in painful gonarthritis: experiences from a retrospective East German bicenter study. Radiat Oncol. 8(1):29 (2013). PMID:23369282.
  • Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis E, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, Harrison JD, Hildebrandt G, Ivanov V, Kashcheev VV, Klymenko SV, Laurent O, Ozasa K, Tapio S, Taylor AM, Tzoulaki I, Vandoolaeghe WL, Wakeford R, Zablotska L, Zhang W, Lipshultz SE. Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat Environ Biophys. 51:165-178 (2012)) by Schöllnberger et al. Radiat Environ Biophys. 52(1): 157-9 (2013). PMID:23296519.
  • Mitchel RE, Hasu M, Bugden M, Wyatt H, Hildebrandt G, Chen YX, Priest ND, Whitman SC. Low-dose radiation exposure and protection against atherosclerosis in ApoE(-/-) mice: the influence of P53 heterozygosity. Radiat Res. 179(2):190-9 (2013). PMID:23289388.
  • Kadhim M, Salomaa S, Wright E, Hildebrandt G, Belyakov OV, Prise KM, Little MP. Non-targeted effects of ionising radiation-Implications for low dose risk. Mutat Res. 752(2):84-98 (2013). PMID:23262375.
  • Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol. 109(1):13-20 (2013). PMID:24183066.
  • Nieder C, Pawinski A, Andratschke NH. Combined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations. Front Oncol. 3:176 (2013). PMID:23847765.
  • Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy  R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N. Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.J Thorac Oncol. 8(8):1050-8 (2013). PMID:23817193.
  • Essler M, Wantke J, Mayer B, Scheidhauer K, Bundschuh RA, Haller B, Astner ST, Molls M, Andratschke N. Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy. Strahlenther Onkol. 189(6):495-501 (2013). PMID:23609133.
  • Nieder C, Andratschke NH, Grosu AL. Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. Am J Cancer Res. 3(2):152-8 (2013). PMID:23593538.
  • Buttler D, Mai JK, Ashwell KW, Andressen C. Clonogenic CD15 immunoreactive radial glial cells from the developing human lateral ganglionic eminence.Curr Pharm Biotechnol. 14(1):29-35 (2013). PMID: 23092258.
  • Jaeger A, Baake J, Weiss DG, Kriehuber R. Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells. Int J Dev Neurosci. 31(1):61-8 (2013). PMID:23085082.
  • Levitskaya NV, Lewitzki V, Komarov IG, Nemtsova MV, Poddubnaya IV. CUP-syndrome: the present view of the problem (a review of literature). Moderne Methoden in der Onkologie (Russ. Zeitschrift). 15(1):41-46 (2013).
  • Siewert U, Hoffmann W, Zettl H. Zentrales Klinisches Krebsregister, Gemeinsam für die Qualitätssicherung in der Onkologie in M-V. DENS. 2:24-27 (2013).
  • Siewert U, Freund M, Scriba S, Schreier V, Dölken G, Hildebrandt G, Zettl H, Dommisch K, Grobe N, Steiner L, Hoffmann W. Die Klinischen Krebsregister und das Zentrale Klinische Krebsregister Mecklenburg-Vorpommern: Gemeinsam für die Qualitätssicherung in der Onkologie. Ärzteblatt Mecklenburg-Vorpommern. 2:45-53 (2013).
  • Fernandez-Palomo C, Bräuer-Krisch E, Trippel M, Schroll C, Requardt H, Bartzsch S, Nikkhah G, Schültke E. DNA double strand breaks in the acute phase after synchrotron pencilbeam irradiation. JINST. 8 (2013).
  • Schültke E, Nanko N, Pinsker M, Katzev M, Sebastian A, Feige B, Nikkhah G. Improving MRT image quality in patients with movement disorders.Acta Neurochir Suppl. 117:13-7 (2013). PMID:23652651.
  • Schültke E, Menk R, Stampanoni M, Arfelli F, Astolfo A, Hall C, Pinzer B, Tromba G. Can we develop an early warning system for patients after cell transplantation therapy using X-ray imaging?JINST. 8 (2013).
  • Schültke E, Trippel M, Bräuer-Krisch E, Renier M, Bartzsch S, Requardt H, Döbrössy MD, Nikkhah G. Pencilbeam irradiation technique for whole brain radiotherapy: Technical and biological challenges in a small animal model.PLOS One. 8(1):e54960 (2013). PMID: 23383014.
  • Mothersill C, Fernandez-Palomo C, Fazzari J, Smith R, Schültke E, Bräuer-Krisch E, Laissue A, Schroll C, Seymour C. Transmission of signals from rats receiving high doses of microbeam radiotherapy to cage mates: an inter-mammal bystander effect.Dose Response. 12(1):72-92 (2013). PMID:24659934. 
  • Astolfo A, Arfelli F, Schültke E, James S, Mancini L, Menk RH. A detailed study of gold-nanoparticle loaded cells using X-ray based techniques for cell-tracking applications with single-cell sensitivity.Nanoscale. 5(8):3337-45 (2013). PMID:23467621.
  • Lopez WO, Nikkhah G, Kahlert UD, Maciaczyk D, Bogiel T, Moellers S, Schültke E, Döbrössy M, Maciaczyk J. Clinical neurotransplantation protocol for Huntington's and Parkinson's disease. Restor Neurol Neurosci. 31(5):579-95 (2013). PMID:23777636.
  • Fernandez-Palomo C, Schültke E, Smith R, Bräuer-Krisch E, Laissue J, Schroll C, Fazzari J, Seymour C, Mothersill C. Bystander effects in tumour-free and tumor-bearing rat brains following irradiation by synchrotron X-rays.Int J Radiat Biol. 89(6):445-53 (2013) PMID:23363251.
  • Astolfo A, Schültke E, Menk RH, Hall C, Juurlink B, Arfelli F. X-ray cell tracking: from ex-vivo to in vivo experiments. JINST. 8 (2013).
  • Smith RW, Wang J, Schültke E, Seymour CB, Bräuer-Krisch E, Laissue JA, Blattmann H, Mothersill CE. Proteomic changes in the rat brain induced by homogenous irradiation and by the bystander effect resulting from high energy synchrotron X-ray microbeams.Int J Radiat Biol. 89(2):118-27 (2013). PMID:23004567.
  • Astolfo A, Schültke E, Menk RH, Hall C, Kirch R, Stebel M, Harsan L, Juurlink BHJ, Arfelli F. In vivo visualization of gold loaded cells in mice using x-ray computed tomography.Nanomedicine. 9(2):284-92 (2013). PMID:22841913.

Publikationen 2012

  • Baumgart T, Klautke G, Kriesen S, Kuznetsov S, Weiss DG, Fietkau R, Hildebrandt G, Manda K. Radiosensitizing effect of epothilone B on human epithelial cancer cells.Strahlenther Onkol. 188(2):177-184 (2012). PMID:22234539.
  • Rödel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K, Schöllnberger H, Hildebrandt G, Rödel C. Modulation of Inflammatory Immune Reactions by Low-dose Ionizing Radiation: Molecular Mechanisms and Clinical Application.Curr Med Chem. 19(12):1741-1750 (2012). PMID:22414082.
  • Manapov F, Klöcking S, Niyazi M, Levitskiy V, Belka C, Hildebrandt G, Fietkau R, Klautke G. Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival.J Neurooncol. 109(2):309-314 (2012). PMID:22610939.
  • Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis E, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, Harrison JD, Hildebrandt G, Ivanov V, Kashcheev VV, Klymenko SV, Kreuzer M, Laurent O, Ozasa K, Schneider T, Tapio S, Taylor AM, Tzoulaki I, Vandoolaeghe WL, Wakeford R, Zablotska LB, Zhang W, Lipshultzs SE. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks.Environ Health Perspect. 120(11):1503-1511 (2012).
  • Krause J, Blanck O, Duerichen R, Wurster S, Andratschke N, Rades D, Hildebrandt G, Dunst J, Schweikard A, Schlaefer A. Retrospective Accuracy Estimation for Motion Compensated Robotic Radio-surgery of the Liver.Medical Physics. 39(6):3985 (2012).
  • Baumgart T, Kriesen S, Hildebrandt G, Manda K. Effect of Epothilone B on cell cycle, metabolic activity, and apoptosis induction on human epithelial cancer cells - under special attention of combined treatment with ionizing radiation.Cancer Invest. 30(8):593-603 (2012). PMID:22909073.
  • Manda K, Glasow A, Paape D, Hildebrandt G. Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells.Front Oncol. 2:102 (2012). PMID:22937525.
  • Tiemann N, Hildebrandt G, Manda K. Unexpected effect of the monoclonal antibody Panitumumab on human cancer cells with different KRAS status. Med Oncol. 29(3):2276-83 (2012). PMID:21842425.
  • Schweyen R, Hey J, Fränzel W, Vordermark D, Hildebrandt G, Kuhnt T. Radiogene Karies: Ätiologie und Möglichkeiten der Prävention. Was sollte der Strahlentherapeut wissen?Strahlenther Onkol. 188:21-8 (2012).
  • Gottschling S, Herpel E, Eberhardt WE, Heigener DF, Fischer JR, Köhne CH, Kortsik C, Kuhnt T, Muley T, Meister M, Bischoff HG, Klein P, Moldenhauer I, Schnabel PA, Thomas M, Penzel R. The gefitinib long-term responder (LTR)-a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP).Lung Cancer. 77(1):183-91 (2012). PMID:22483783.
  • Hey J, Seidel J, Schweyen R, Paelecke-Habermann Y, Vordermark D, Gernhardt C, Kuhnt T. The influence of parotid gland sparing on radiation damages of dental hard tissues. Clin Oral Investig. 17(6):1619-25 (2012). PMID:23053706.
  • Oertel K, Spiegel K, Schmalenberg H, Dietz A, Maschmeyer G, Kuhnt T, Sudhoff H, Wendt TG, Guntinas-Lichius O. Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). BMC Cancer. 12:483 (2012). PMID:23083061.
  • Mikolasch A, Manda K, Schlüter R, Lalk M, Witt S, Seefeldt S, Hammer E, Schauer F, Jülich WD, Lindequist U. Comparative analyses of laccase-catalyzed amination reactions for production of novel beta-lactam antibiotics.Biotechnol Appl Biochem. 59(4):295-306 (2012). PMID:23586863.
  • Rödel F, Frey B, Manda K, Hildebrandt G, Hehlgans S, Keilholz L, Seegenschmiedt MH, Gaipl US and Rödel C. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose X-irradiation.Front Oncol. 2(120):1-9 (2012). PMID:23057008.
  • Nieder C, Andratschke NH, Geinitz H, Grosu AL. Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries.Med Sci Monit. 18(7):CR450-5 (2012). PMID:22739735.
  • Andratschke N. Stereotactic ablative radiotherapy for inoperable stage I NSCLC.Lancet Oncol. 13(8):746-8 (2012). PMID:22727221.
  • Nieder C, Grosu AL, Spanne O, Andratschke NH, Geinitz H. Brain metastases in patients under 50 years of age: retrospective analysis.Clin Exp Metastasis. 29(8):949-56 (2012). PMID:22644728.
  •  Nieder C, Andratschke NH, Geinitz H, Grosu AL. Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies.Strahlenther Onkol. 188(8):692-5 (2012). PMID:22526229.
  • Nieder C, Grosu AL, Marienhagen K, Andratschke NH, Geinitz H. Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases.Med Oncol. 29(4):2664-8 (2012). PMID:22467077.
  • Bundschuh RA, Andratschke N, Dinges J, Duma MN, Astner ST, Brügel M, Ziegler SI, Molls M, Schwaiger M, Essler M. Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.Strahlenther Onkol. 188(7):592-8 (2012). PMID:22441441.
  • Duma MN, Kampfer S, Schuster T, Aswathanarayana N, Fromm LS, Molls M, Andratschke N, Geinitz H. Do we need daily image-guided radiotherapy by megavoltage computed tomography in head and neck helical tomotherapy? The actual delivered dose to the spinal cord. Int J Radiat Oncol Biol Phys. 84(1):283-8 (2012). PMID:22417803.
  • Nieder C, Andratschke N. Adding cetuximab to stereotactic radiotherapy for non-small cell lung cancer might reduce local failure rates.Med Hypotheses. 78(4):420-2 (2012). PMID:22281370.
  • Nieder C, Pawinski A, Dalhaug A, Andratschke N. A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer.Radiat Oncol. 7:3 (2012). PMID:22236606. 

Publikationen 2011

  • Hilgendorf  I, Freund M, Kropp P, Hartmann S, Krogmann D, Daunke A, Klasen J, Klöcking S, Zettl H, Classen CF. Onkologische Erkrankungen bei Jugendlichen und jungen Erwachsenen – Zahlen aus dem Klinischen Krebsregister Rostock als Arbeitsgrundlage für eine interdisziplinäre Herausforderung. TumorDiagn u Ther. 32:85-92 (2011).
  • Nieder C, Bremnes RM, Andratschke N. Prognostic scores in patients with brain metastases from non-small cell lung cancer.J Thorac Oncol. 4(11):1337-41 (2011). PMID:19701108.
  • Nieder C, Astner ST, Andratschke N, Marienhagen K. Postoperative treatment and prognosis of patients with resected single brain metastasis: how useful are established prognostic scores?Clin Neurol Neurosurg. 113(2):98-103 (2011). PMID:20947246.
  • Nieder C, Andratschke N, Spanne O, Geinitz H, Grosu AL. Does overall treatment time impact on survival after whole-brain radiotherapy for brain metastases?Clin Transl Oncol. 13(12):885-888 (2011). PMID:22126732.
  • Andratschke N, Zimmermann F, Boehm E, Schill S, Schoenknecht C, Thamm R, Molls M, Nieder C, Geinitz H. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother Oncol. 101(2):245-249 (2011). PMID:21724287.
  • Andratschke N, Blau T, Schill S, Nieder C. Late residual gamma-H2AX foci in murine spinal cord might facilitate development of response-modifying strategies: a research hypothesis.Anticancer Res. 31(2):561-564 (2011). PMID:21378339.
  • Andratschke N, Maurer J, Molls M, Trott KR. Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanism and strategies of prevention. Radiother Oncol. 100(2):160-166 (2011). PMID:20826032.
  • Lindholm C, Acheva A, Koivistoinen A, Perala M, Heinavaara S, Jahns J, Salomaa S, Hildebrandt G. Search for Clastogenic Factors in the Plasma of Locally Irradiated Individuals.Radiat Res. 177(3):298-306 (2011). PMID:22165823.
  • Schubert K, Polte T, Bonisch U, Schader S, Holtappels R, Hildebrandt G, Lehmann J, Simon JC, Anderegg U, Saalbach A. Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation.Eur J Immunol. 41(3):645-56 (2011). PMID:21264853.
  • Mitchel RE, Hasu M, Bugden M, Wyatt H, Little MP, Gola A, Hildebrandt G, Priest ND, Whitman SC. Low-dose radiation exposure and atherosclerosis in ApoE/mice.Radiat Res. 175(5):665-76 (2011). PMID:21375359.
  • Jahns J, Anderegg U, Saalbach A, Rosin B, Patties I, Glasow A, Kamprad M, Scholz M, Hildebrandt G. Influence of low dose irradiation on differentiation, maturation and T-cell activation of human dendritic cells.Mutat Res. 709-710:32-39 (2011). PMID:21376737.
  • Heckers KO, Schmidt V, Krastel D, Hildebrandt G, Kiefer I, Pees M. Malignant melanophoroma in a Hermann s tortoise (Testudo hermanni). A case report.Tierarztl Prax Ausg K Kleintiere Heimtiere. 39(1):45-50 (2011).
  • Hey J, Setz J, Gerlach R, Janich M, Hildebrandt G, Vordermark D, Gernhardt CR, Kuhnt T. Parotid gland-recovery after radiotherapy in the head and neck region-36 months follow-up of a prospective clinical study. Radiat Oncol. 6:125 (2011). PMID:21951317.
  • Manapov F, Klöcking S, Niyazi M, Belka C, Hildebrandt G, Fietkau R, Klautke G. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.Strahlenther Onkol. 188(1):29-34 (2011). PMID:22189436.
  • Manda K, Kriesen S, Hildebrandt G, Fietkau R, Klautke G. Omega-3 fatty acid supplementation in cancer therapy: does eicosapentanoic acid influence the radiosensitivity of tumor cells?Strahlenther Onkol. 187(2):127-34 (2011). PMID:21267532.
  • Schweyen R, Hey J, Franzel W, Vordermark D, Hildebrandt G, Kuhnt T. Radiation-related caries: etiology and possible preventive strategies: What should the radiotherapist know?Strahlenther Onkol. 188(1):21-8 (2011). PMID:22189435.
  • Kuhnt T, Klockenbrink U, Knipping S, Lautermann J, Kriese K, Wienke A, Hildebrandt G, Hauptmann S. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases. Strahlenther Onkol. 187(5):292-9 (2011). PMID:21533760.
  • Sadat F, Wienke A, Dunst J, Kuhnt T. Survival of patients with head and neck cancer: Impact of physical status and comorbidities. Strahlenther Onkol. 188(1):62-70 (2011). PMID:22189439.
  • Huber S, Oelsner M, Decker T, zum Buschenfelde CM, Wagner M, Lutzny G, Kuhnt T, Schmidt B, Oostendorp RA, Peschel C, Ringshausen I. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.Leukemia. 25(5):838-47 (2011). PMID:21293487.
  • Gottschling S, Penzel R, Pelz T, Herpel E, Schnabel PA, Dyckhoff G, Thomas M, Kuhnt T. KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib: a case report and review of the literature.J Clin Oncol. 29(21):e616-9 (2011). PMID:21555681.
  • Hahn V, Mikolasch A, Manda K, Gordes D, Thurow K, Schauer F. Derivatization of amino acids by fungal laccases: Comparison of enzymatic and chemical methods.J Mol Catal B Enzyme. 60(1-2):76-81 (2011). ISSN:1381-1177.
  • Mikolasch A, Hessel S, Salazar MG, Neumann H, Manda K, Gordes D, Schmidt E, Thurow K, Hammer E, Lindequist U, Beller M, Schauer F. Synthesis of new N-analogous corollosporine derivatives with antibacterial activity by laccase-catalyzed amination. Chem Pharm Bull. 56(6):781-6 (2011). PMID:18520080.
  • Kamysek S, Fuchs P, Schwoebel H, Roesner JP, Kischkel S, Wolter K, Loeseken C, Schubert JK, Miekisch W. Drug detection in breath: effects of pulmonary blood flow and cardiac output on propofol exhalation.Anal Bioanal Chem. 401(7):2093-102 (2011). PMID:21643859.
  • Hilgendorf I, Freund M, Kropp P, Hartmann S, Krogmann D, Daunke A, Klasen J, Klöcking S, Zettl H, Classen CF. Onkologische Erkrankungen bei Jugendlichen und jungen Erwachsenen. TumorDiagn u Therapie. 32(2): 85-92 (2011).

Publikationen 2010

  • Hildebrandt G. Non-cancer diseases and non-targeted effects.Mutat Res. 687(1-2):73-7 (2010). PMID:20097211.
  • Jacquet P, Buset J, Neefs M, Vankerkom J, Benotmane MA, Derradji H, Hildebrandt G, Baatout S. Transgenerational developmental effects and genomic instability after X-irradiation of preimplantation embryos: studies on two mouse strains.Mutat Res. 687(1-2):54-62 (2010). PMID:20096709.
  • Bogdándi EN, Balogh A, Felgyinszki N, Szatmári T, Persa E, Hildebrandt G, Sáfrány G, Lumniczky K. Effects of low-dose radiation on the immune system of mice after total-body irradiation.Radiat Res. 174(4):480-9 (2010). PMID:20726712.
  • Ott OJ, Hildebrandt G, Pötter R, Hammer J, Hindemith M, Resch A, Spiegl K, Lotter M, Uter W, Kortmann RD, Schrauder M, Beckmann MW, Fietkau R, Strnad V. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence.Int J Radiat Oncol Biol Phys. 80(5):1458-63 (2010). PMID:20675064.
  • Strnad V, Hildebrandt G, Pötter R, Hammer J, Hindemith M, Resch A, Spiegl K, Lotter M, Uter W, Bani M, Kortmann RD, Beckmann MW, Fietkau R, Ott OJ. Accelerated Partial Breast Irradiation: 5-Year Results of the German-Austrian Multicenter Phase II Trial Using Interstitial Multicatheter Brachytherapy Alone After Breast-Conserving Surgery. Int J Radiat Oncol Biol Phys. 80(1):17-24 (2010). PMID:20605365.
  • Höckel M, Kahn T, Einenkel J, Manthey N, Braumann UD, Hildebrandt G, Leo C, Hentschel B, Vaupel P, Horn LC. Local spread of cervical cancer revisited: a clinical and pathological pattern analysis.Gynecol Oncol. 117(3):401-8 (2010). PMID:20236693.
  • Polgár C, Van Limbergen E, Pötter R, Kovács G, Polo A, Lyczek J, Hildebrandt G, Niehoff P, Guinot JL, Guedea F, Johansson B, Ott OJ, Major T, Strnad V; GEC-ESTRO breast cancer working group. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence.Radiother Oncol. 94(3):264-73 (2010). PMID:20181402.
  • Rödel F, Frey B, Capalbo G, Gaipl U, Keilholz L, Voll R, Hildebrandt G, Rödel C. Discontinuous induction of X-linked inhibitor of apoptosis in EA.hy.926 endothelial cells is linked to NF-κB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation. Radiother Oncol. 97(2):346-51 (2010). PMID:20170972.
  • Salomaa SI, Wright EG, Hildebrandt G, Kadhim MA, Little MP, Prise KM, Belyakov OV. Editorial.Non-DNA targeted effects. Mutat Res. 687(1-2):1-2 (2010). PMID:20100499.
  • Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W, Niederwieser D, Dollner R, Remmerbach TW, Wittekind C, Dietzsch S, Hildebrandt G, Wichmann G. Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol. 267(4):483-94 (2010). PMID:20052589.
  • Kuhnt T, Janich M. Principles of radiation therapy for malignant tumors of the orbit and the periorbital area.HNO. 58(1):15-23 (2010). PMID:20012000.
  • Kuhnt T, Sandner A, Wendt T, Engenhart-Cabillic R, Lammering G, Flentje M, Grabenbauer G, Schreiber A, Pirnasch A, Dunst J. Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck.Ann Oncol. 21(11):2284-9 (2010). PMID:20427347.
  • Little, MP, Tawn, EJ, Tzoulaki, I, Wakeford, R, Hildebrandt, G, Paris, F, Tapio, S, Elliott, P: Review and meta-analysis of epidemiological associations between low and moderate doses of ionizing radiation and late circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys. 49(2):139-153 (2010). PMID: 19862545

Publikationen 2009

  • Hey J, Setz J, Gerlach R, Janich M, Sehlleier S, Schaller HG, Gernhardt CR, Kuhnt T. Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region-Results in clinical practice.Oral Oncol. 45(2):e11-7 (2009). PMID:18621572.
  • Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Tapio S. Comments: The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946–2005.Int J Epidemiol. 38(4):1159-1164 (2009). PMID:18614611.
  • Patties I, Jahns J, Hildebrandt G, Kortmann RD, Glasow A. Additive effects of 5-aza-2’-deoxycytidine and irradiation on clonogenic survival of human medullo-blastoma cell lines.Strahlenther Onkol. 185(5):331-338 (2009). PMID:19440673.
  • Fricke S, Ackermann M, Stolzing A, Hilger N, Schimmelpfennig C, Jahns J, Hildebrandt G, Emmrich F, Boltze J, Kamprad M, Sack U. Allogeneic nonadherent stem cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment.PLoS One. 4(7):e6157 (2009). PMID:19582154.
  • Böttcher P, Krastel D, Hierholzer J, Westphalen K, Florian S, Hildebrandt G, Grevel V, Oechtering G. Percutaneous cementoplasty in the palliative, multimodal treatment of primary bone tumors of the distal aspect of the radius in four dogs.Vet Surg. 38(7):888-901 (2009). PMID:19781033.
  • Schultz-Hector S, Hildebrandt G. Investigation of biological mechanisms of radiation induced circulatory diseases - Part II: Analysis of published results and ongoing research in European projects.EU Radiation Protection. No.158:47-60 (2009).
  • Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Paris F, Tapio S, Elliott P. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys. 49(2):139-53 (2009). PMID:19862545.
  • Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy. Int J Radiat Oncol Biol Phys. 75(5):1475-80 (2009). PMID:19515505.
  • Bekes K, Francke U, Schaller HG, Kuhnt T, Gerlach R, Vordermark D, Gernhardt CR. The influence of different irradiation doses and desensitizer application on demineralization of human dentin. Oral Oncol. 45(9):e80-4 (2009). PMID:19442566.
  • Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol. 266(8):1291-300 (2009). PMID:18972123.
  • Kuhnt T, Klockenbrink U, Pelz T, Wienke A, Janich M, Sandner A, Lautermann J, Vordermark D, Schubert J. Postoperative radiotherapy versus concurrent radiochemotherapy for locally advanced squamous cell carcinoma of the oral cavity and the oropharynx. A retrospective analysis of high-risk patients. NAMJ. 3(3):11-21 (2009). ISSN1820-0254.
  • Lange S, Altmann S, Brandt B, Adam C, Riebau F, Vogel H, Weirich V, Hilgendorf I, Storb R, Freund M, Junghanss C. Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model. Exp Hematol. 37(1):143-50 (2009). PMID:19100524.
  • Kalata P, Martus P, Zettl H, Rödel C, Hohenberger W, Raab R, Becker H, Liersch T, Wittekind C, Sauer R, Fietkau R. Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry.Dis Colon Rectum. 52(3):425-37 (2009). PMID:19333042.